Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+9.01%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$46.3B
AUM Growth
+$5.71B
(+14%)
Cap. Flow
+$2.71B
Cap. Flow
% of AUM
5.85%
Top 10 Holdings %
Top 10 Hldgs %
21.72%
Holding
2,977
New
596
Increased
632
Reduced
646
Closed
724
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.1B |
| 2 |
Microsoft
MSFT
|
+$567M |
| 3 |
Advanced Micro Devices
AMD
|
+$559M |
| 4 |
Amazon
AMZN
|
+$363M |
| 5 |
Apple
AAPL
|
+$353M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$388M |
| 2 |
McDonald's
MCD
|
+$386M |
| 3 |
Visa
V
|
+$380M |
| 4 |
Meta Platforms (Facebook)
META
|
+$371M |
| 5 |
Adobe
ADBE
|
+$330M |
Sector Composition
| 1 | Technology | 21.67% |
| 2 | Healthcare | 18.8% |
| 3 | Consumer Discretionary | 14.72% |
| 4 | Financials | 8.87% |
| 5 | Industrials | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LGTY
1726
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $259K | ﹤0.01% |
24,609
-48,200
| -66% | -$507K |
|
1727
GSI Technology
GSIT
$96.6M
| $256K | ﹤0.01% |
+46,319
| New | +$256K |
|
|
ADAP
1728
Adaptimmune Therapeutics
ADAP
$13.4M
| $254K | ﹤0.01% |
+272,681
| New | +$254K |
|
1729
Virtu Financial
VIRT
$3.14B
| $253K | ﹤0.01% |
+14,822
| New | +$253K |
|
1730
Acco Brands
ACCO
$372M
| $252K | ﹤0.01% |
+48,320
| New | +$252K |
|
1731
PTC Therapeutics
PTCT
$4.84B
| $251K | ﹤0.01% |
+6,182
| New | +$251K |
|
1732
Immatics
IMTX
$720M
| $250K | ﹤0.01% |
+21,700
| New | +$250K |
|
1733
NVE Corp
NVEC
$328M
| $249K | ﹤0.01% |
2,558
-2,806
| -52% | -$273K |
|
|
CAMP
1734
DELISTED
CalAmp Corp.
CAMP
| $249K | ﹤0.01% |
10,193
-1,123
| -10% | -$27.4K |
|
1735
Dyne Therapeutics
DYN
$1.88B
| $248K | ﹤0.01% |
22,052
-110,292
| -83% | -$1.24M |
|
|
CBIO
1736
Crescent Biopharma, Inc. Common Stock
CBIO
$174M
| $248K | ﹤0.01% |
1,424
-739
| -34% | -$129K |
|
1737
Rocket Companies
RKT
$44.4B
| $247K | ﹤0.01% |
27,600
-73,813
| -73% | -$661K |
|
1738
RXO
RXO
$2.81B
| $247K | ﹤0.01% |
10,879
-92,515
| -89% | -$2.1M |
|
1739
OrthoPediatrics
KIDS
$510M
| $245K | ﹤0.01% |
+5,597
| New | +$245K |
|
1740
Toll Brothers
TOL
$14.2B
| $245K | ﹤0.01% |
+3,100
| New | +$245K |
|
1741
Climb Global Solutions
CLMB
$603M
| $243K | ﹤0.01% |
+5,077
| New | +$243K |
|
1742
Consensus Cloud Solutions
CCSI
$537M
| $242K | ﹤0.01% |
+7,797
| New | +$242K |
|
|
ICPT
1743
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $241K | ﹤0.01% |
21,820
-91,501
| -81% | -$1.01M |
|
1744
Smart Sand
SND
$75.5M
| $241K | ﹤0.01% |
147,066
-18,917
| -11% | -$31K |
|
1745
Invesco KBW Property & Casualty Insurance ETF
KBWP
$482M
| $237K | ﹤0.01% |
2,900
-1,400
| -33% | -$115K |
|
|
BCYC
1746
Bicycle Therapeutics
BCYC
$487M
| $237K | ﹤0.01% |
9,271
-67,378
| -88% | -$1.72M |
|
1747
STAAR Surgical
STAA
$1.39B
| $237K | ﹤0.01% |
4,500
+600
| +15% | +$31.5K |
|
1748
Vera Therapeutics
VERA
$1.57B
| $236K | ﹤0.01% |
14,699
-30,087
| -67% | -$483K |
|
1749
SCYNEXIS
SCYX
$49.5M
| $235K | ﹤0.01% |
+79,519
| New | +$235K |
|
1750
Microvision
MVIS
$346M
| $234K | ﹤0.01% |
+51,147
| New | +$234K |
|